Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Deva Holding ASIST:DEVA +1.22%66 5-Year Yield-on-Cost % is 0.00 as of Aug. 30, 2026. GuruFocus rates IST:DEVA with a GF Score™ of 66/100 and a GF Value™ of ₺82.76 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 509 Drug Manufacturers companies, Deva Holding AS ranks worse than 196463.46% on this metric.
Deva Holding AS's yield on cost for the quarter that ended in Jun. 2026 was 0.00.
The historical rank and industry rank for Deva Holding AS's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Deva Holding AS's highest Yield on Cost was 0.54. The lowest was 0.15. And the median was 0.34.
IST:DEVA's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.37 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Deva Holding AS (IST:DEVA) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Deva Holding AS 5-Year Yield-on-Cost % Related Terms
IST:DEVA vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Deva Holding AS's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deva Holding AS 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deva Holding AS's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Deva Holding AS's 5-Year Yield-on-Cost % falls into.
Deva Holding AS 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Deva Holding AS is calculated as
Deva Holding AS (IST:DEVA) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 30, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Deva Holding AS and its competitors. Over the past decade, Deva Holding AS's 5-Year Yield-on-Cost % has ranged from 0.15 to 0.54. According to the industry distribution chart, Deva Holding AS ranks #999999 out of 509 companies in the Drug Manufacturers industry.
Is Deva Holding AS's 5-Year Yield-on-Cost % too high?
Deva Holding AS's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 0.54. Based on the distribution chart, Deva Holding AS ranks #999999 out of 509 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Deva Holding AS has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Deva Holding AS's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Deva Holding AS ranks #999999 out of 509 companies for 5-Year Yield-on-Cost %. This places Deva Holding AS in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.37. Historically, Deva Holding AS's own 5-Year Yield-on-Cost % has ranged from 0.15 to 0.54 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.37, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Deva Holding AS and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deva Holding AS's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deva Holding AS stock overvalued right now?
Based on GuruFocus' analysis, Deva Holding AS (IST:DEVA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺82.76, compared to a current price of ₺91.60 — trading 10.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Deva Holding AS's overall GF Score™ is 66/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Deva Holding AS (IST:DEVA), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deva Holding AS (IST:DEVA) Overvalued in 2026?
Based on GuruFocus' analysis, Deva Holding AS stock appears to be overvalued.
The current stock price of ₺91.60 is trading 10.7% above its estimated GF Value™ of ₺82.76.
GuruFocus considers Deva Holding AS to be Modestly Overvalued.
Key valuation signals for IST:DEVA:
5-Year Yield-on-Cost %: 0.00
GF Value™: ₺82.76 vs. price of ₺91.60 (10.7% above fair value)
No single metric tells the full story. See the IST:DEVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
66GF Score
Get the complete analysis for IST:DEVA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:DEVA has been successfully added to your 
